3,4-Dibromo-Mal-PEG4-Val-Cit-PAB-MMAE serves as a peptide linker that can be used in the creation of antibody drug conjugates (ADCs). The dibromomaleimide group allows for two points of substitution due to the two bromine atoms. The cathepsin-cleavable Val-Cit-PAB dipeptide is ligated to an MMAE payload. The PEG4 chain improves the water-solubility of the compound. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.
Usually ships within 24 hours.